Uploaded May 2026 | Updated September 2026, 2 weeks ago
REGISTER for CannMed 26 (June 15-18, 2026) at cannmedevents.com
Dr. Harold Han is the Founder of PhytoRX. He has dedicated his career to the art and science of nanoemulsions, transforming plant-derived active ingredients into stable, predictable and effective formulations.
He founded PhytoRX is to bring consistency and efficacy into the plant-based therapeutics, and give clinicians a tool they can confidently use.
At CannMed 26, Harold will Moderate a panel titled “Drink Your Cannabionoids - How it changes cannabis research and patient care”, which brings together leading clinicians, researchers,, and innovators to explore how emulsion-based cannabinoids are improving outcomes in oncology, geriatrics, and clinical trials.
During our conversation, we discuss:
* How cannabis emulsion technology solvers composition, degradation, and absorption challenges in medical cannabis
* How turning oil-based cannabinoids into water-compatible emulsions improves bioavailability, dosing precision, and patient adherence
* How emulsion-based products improve the "therapeutic window" via predictable PK profiles that smoking, tinctures, and edibles can't match
* Why drinking cannabinoids better fits patients’ existing habits
* A preview of the CannMed Emulsion Panel
* and more
Thanks to this Episode’s Sponsor: PhytoRX
PhytoRX was born from the expertise of Vertosa, a pioneer in advanced infusion technology with years of experience delivering precision and consistency for next-generation botanical therapeutics. The product improves on traditional cannabinoid formats by delivering accurate dosing, rapid absorption, optimized bioavailability, and ease of use.
Go to phytorx.co to learn more, and if you decide to give it a try, use promocode CannMed at checkout to get 15% off.
REGISTER for CannMed 26 (June 15-18, 2026) at cannmedevents.com
Dr. Harold Han is the Founder of PhytoRX. He has dedicated his career to the art and science of nanoemulsions, transforming plant-derived active ingredients into stable, predictable and effective formulations.
He founded PhytoRX is to bring consistency and efficacy into the plant-based therapeutics, and give clinicians a tool they can confidently use.
At CannMed 26, Harold will Moderate a panel titled “Drink Your Cannabionoids - How it changes cannabis research and patient care”, which brings together leading clinicians, researchers,, and innovators to explore how emulsion-based cannabinoids are improving outcomes in oncology, geriatrics, and clinical trials.
During our conversation, we discuss:
* How cannabis emulsion technology solvers composition, degradation, and absorption challenges in medical cannabis
* How turning oil-based cannabinoids into water-compatible emulsions improves bioavailability, dosing precision, and patient adherence
* How emulsion-based products improve the "therapeutic window" via predictable PK profiles that smoking, tinctures, and edibles can't match
* Why drinking cannabinoids better fits patients’ existing habits
* A preview of the CannMed Emulsion Panel
* and more
Thanks to this Episode’s Sponsor: PhytoRX
PhytoRX was born from the expertise of Vertosa, a pioneer in advanced infusion technology with years of experience delivering precision and consistency for next-generation botanical therapeutics. The product improves on traditional cannabinoid formats by delivering accurate dosing, rapid absorption, optimized bioavailability, and ease of use.
Go to phytorx.co to learn more, and if you decide to give it a try, use promocode CannMed at checkout to get 15% off.
